63 results
8-K
EX-99.1
GH
Guardant Health Inc
9 May 24
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
4:11pm
reimbursement,” said Helmy Eltoukhy, co-founder and co-CEO. “In addition to strong topline performance, this was the first quarter of generating positive cash … %, respectively, over the prior year period. The increase in precision oncology revenue was also attributable to an increase in reimbursement for our
8-K
EX-99.1
mxj81xde9y8e
22 Feb 24
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
4:10pm
8-K
EX-99.1
7s9rzxiz 1o1vnk
3 Aug 23
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
4:14pm
8-K
EX-99.1
5qid5qe
15 Dec 22
Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer
4:17pm
8-K
EX-99.1
lyo6 6b6fo1wobw1
3 Nov 22
Guardant Health Reports Third Quarter 2022 Financial Results
4:11pm
DEFA14A
9830 28bnrc3al3v2ick
8 Jun 22
Additional proxy soliciting materials
4:16pm